Clinical Trials Browser

Phase 1 × Neoplasm Metastasis × capmatinib × Clear all

NCT03742349 2025-05-18

Study of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC).

Phase 1 Terminated

Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT01072266 2017-11-22

A Dose-escalation Study in Subjects With Advanced Malignancies

Phase 1 Completed

Neoplasm Metastasis